SOD1 and cancer: Knowing that DNMTs are already targets for FDA approved clinical cancer treatments [95] and that DNMT inhibition is neuroprotective in an axotomy model of MN death [29], we then did a drug experiment in hSOD1 mice testing the therapeutic efficacy of the highly specific DNMT inhibitor RG108.